CTOs on the Move

Orbus Therapeutics

www.orbustherapeutics.com

 
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Orbus Therapeutics raised $18M on 08/21/2015

Similar Companies

Moonlighting Solutions

Moonlighting Solutions is a physician-owned and operated company that provides hospitals with short and long-term physician coverage, specializing in night and weekend call coverage. They also offer permanent placement opportunities for their moonlight...

Sentrix Global Health Communications

Sentrix Global Health Communications is a Short Hills, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DiscoveRx

DiscoveRx is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Fremont, CA. To find more information about DiscoveRx, please visit www.discoverx.com

Genomics Institute of the Novartis Research Foundation (GNF)

Genomics Institute of the Novartis Research Foundation (GNF) is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cergis Billing

Cergis Billing is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.